Egypt leverages diplomacy to advance global health partnerships
Egypt is aligning its foreign diplomacy with national health priorities as part of a broader strategy to enhance international cooperation in the health sector.
On Sunday, Foreign Minister and Minister of Immigration Badr Abdelatty met with Deputy Prime Minister and Minister of Health Khaled Abdel Ghaffar to discuss how Egypt's diplomatic missions abroad can help achieve key health development goals.
The meeting, held as part of a series of briefings for newly appointed ambassadors, focused on ways embassies can support the Ministry of Health by attracting foreign investment, fostering international partnerships, and promoting knowledge exchange—particularly in pharmaceutical manufacturing, a sector in which Egypt is emerging as a regional leader.
Abdelatty emphasized the strategic role of diplomacy in positioning Egypt as a hub for the pharmaceutical industry, with enhanced access to African, Central Asian, and select European markets.
Minister Abdel Ghaffar detailed Egypt's ongoing health reforms, including high-profile initiatives such as the eradication of hepatitis C and malaria—milestones that have garnered global recognition. He also highlighted the expansion of healthcare infrastructure and increased public investment aimed at ensuring equitable access to medical services across the country.
A key focus of the discussion was the Universal Health Insurance Project, launched in 2019, which aims to provide comprehensive healthcare coverage to all Egyptians. Abdel Ghaffar called for continued international support, both technical and financial, to help advance the program and reinforce Egypt's role in global health cooperation.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Arabian Business
10 hours ago
- Arabian Business
Middle East pharma market to hit $36bn by 2028 as GCC accelerates innovation and manufacturing
The Middle East's life sciences sector is poised for rapid growth, with the pharmaceutical market expected to reach $36bn by 2028, according to the latest EMEA Life Sciences Industry Perspective and Cluster Report by JLL. Supported by major government investment in research, manufacturing infrastructure, and digital transformation, the region's market is on track to grow at a compound annual growth rate (CAGR) of 7.7 per cent from 2023. The report highlights the strategic pivot across the Gulf Cooperation Council (GCC) to develop local capabilities, reduce import dependence, and diversify national economies. Middle East pharma market boom For the first time, the JLL report includes a detailed focus on the Middle East, revealing how the region is transforming into a hub for life sciences innovation, spanning biopharma research, digital health, and pharmaceutical manufacturing. These trends are reshaping demand for specialised real estate, including flexible R&D spaces, digital health facilities, and state-of-the-art manufacturing hubs. Mireille Azzam, Head of Strategic Consulting, JLL Middle East and Africa (MEA) said: 'Innovation is critical for success in the life sciences industry, and the GCC is building self-reliance by incubating innovative ventures and creating a collaborative environment to scale research and expand its pool of skilled workforce. 'From flexible lab designs and resilient building systems, the increased focus on creating spaces primed for scientific breakthroughs and growth is directly translating into a dynamic real estate market. 'The growing demand for purpose-built facilities will support groundbreaking research, advanced manufacturing, and drive digital transformation, laying a strong foundation for the future growth of the region's evolving life sciences ecosystem.' Key factors accelerating the industry include: Government incentives for local drug manufacturing and biosimilar development Rising prevalence of chronic diseases and demand for personalised medicine Strong focus on telehealth, AI diagnostics, and remote patient monitoring Increased venture capital funding and AI-powered innovation across labs and distribution Strategic locations with advanced logistics and energy-efficient infrastructure The report outlines how major GCC countries are becoming hotspots for life sciences clusters: Biopharma R&D Dubai Science Park and Qatar Science and Technology Park are regional innovation centres Saudi Arabia is expanding its role in drug discovery through strategic partnerships Digital Health Dubai Healthcare City, Healthpoint Abu Dhabi, and NEOM are leading the push in AI, telehealth, and health-tech startups Pharmaceutical Manufacturing Jebel Ali Free Zone, Dubai Industrial City, King Abdullah Economic City, and Sudair Industrial City offer state-of-the-art industrial parks Competitive advantages include low-cost energy, strategic geography, and high local content requirements The shift from public or owner-occupied labs to investor-supplied real estate is solving long-standing shortages of lab space. JLL notes that demand is now focused on next-generation lab facilities, resilient building systems and more sustainable lab designs This change is helping the GCC region align with global leaders like the Golden Triangle (UK), Johannesburg, and Singapore in life sciences innovation. The region's academic strength also plays a key role, with institutions like King Saud University, Qatar University, and United Arab Emirates University earning recognition in global life sciences rankings.
Zawya
16 hours ago
- Zawya
Middle East pharma market on track for $36bln by 2028
JLL's EMEA Life Sciences Industry Perspective and Cluster Report reveals AI and venture capital are fuelling a surge in demand for next-generation labs The Middle East's pharmaceutical market is projected to reach US$36 billion by 2028, with a CAGR of 7.7% from 2023 GCC governments are prioritizing digital transformation and investing in local generic drug manufacturing and biosimilar development to boost sector growth Dubai, United Arab Emirates: Fuelled by significant government investments in R&D and manufacturing infrastructure, and a strategic push towards greater local innovation and production, the Middle East's life sciences industry is poised for substantial growth, according to JLL's latest EMEA Life Sciences Industry Perspective and Cluster Report. The region's pharmaceutical market is projected to reach US$36 billion by 2028, and this robust expansion, set for a Compound Annual Growth Rate (CAGR) of 7.7% from 2023, is further amplified by digital transformation initiatives and comprehensive industrialisation strategies across the Gulf Cooperation Council (GCC). As the life sciences market develops globally, countries in the GCC are accelerating their capabilities in the sector to boost innovation, reduce import reliance, and diversify their economies. The JLL report, which explores the key drivers shaping EMEA's life sciences industry and its impact on real estate markets, has included a high-level overview of the Middle East for the first time. The report reveals that the GCC's pivot towards becoming a global hub for life sciences innovation, research, and production is boosting demand for specialised real estate, including adequate office spaces for R&D and digital health, and manufacturing locations that require warehouse and distribution assets. Mireille Azzam, Head of Strategic Consulting, JLL Middle East and Africa (MEA) said:'Innovation is critical for success in the life sciences industry, and the GCC is building self-reliance by incubating innovative ventures and creating a collaborative environment to scale research and expand its pool of skilled workforce. From flexible lab designs and resilient building systems, the increased focus on creating spaces primed for scientific breakthroughs and growth is directly translating into a dynamic real estate market. The growing demand for purpose-built facilities will support groundbreaking research, advanced manufacturing, and drive digital transformation, laying a strong foundation for the future growth of the region's evolving life sciences ecosystem.' Amidst increasing global competition and tariff uncertainty, JLL's latest report highlights several overarching trends shaping the life sciences real estate landscape across EMEA. Artificial Intelligence (AI) and venture capital are driving demand for next-generation labs, and the report highlights AI's dual impact in accelerating scientific discovery and revolutionising real estate management through increased efficiency from research to distribution. New supply delivered by investors is progressively addressing historical lab space shortages, shifting away from public or owner-occupier driven models, with top-tier assets in prime locations expected to prevail. The JLL report highlights that the sector's commitment to sustainability is driving demand for greener lab buildings. These dynamics underscore how life sciences clusters, from Europe to the Middle East and Africa, possess distinctive strengths, with locations like the Golden Triangle, Johannesburg, and Riyadh leading in biopharma research, while others excel in digital health or manufacturing. The GCC's increasing commitment to life sciences JLL's analysis of the major life sciences city-clusters in the GCC reveals significant transformations across the three prominent subsectors of Biopharma R&D, Digital Health and Tech R&D, and Pharmaceutical Manufacturing. Driven by the increasing prevalence of chronic diseases and a focus on personalised medicine and genomics research, JLL notes a profound shift in the Biopharma and drug discovery sector. As targeted therapies gain prominence, government investments in local generic drug manufacturing and biosimilar development are accelerating, with innovative research in cell and gene therapy also primed for significant growth. Dubai Science Park in the UAE and Qatar Science and Technology Park have emerged as regional hubs for biopharma R&D, while Saudi Arabia's position in the regional drug discovery landscape is strengthened through strategic partnerships and ongoing investments in pharmaceutical research and manufacturing. To improve accessibility, efficiency, and patient outcomes in the healthcare sector, GCC governments have prioritised digital transformation, driving growth in telehealth, remote patient monitoring, and AI-powered diagnostics. The emergence of health-tech startups and a growing emphasis on preventive healthcare are also contributing to sector growth. Regional hubs such as the UAE's Dubai Healthcare City and Healthpoint in Abu Dhabi, and Saudi Arabia's NEOM project are driving the surge in digital health adoption and investment, and fostering innovation and attracting talent. Through investments in industrial parks and by providing incentives for manufacturers, GCC governments are diversifying the region's Pharmaceutical Manufacturing sector. Alongside the adoption of advanced manufacturing technologies to boost efficiencies, growth in this sector is driven by affordable energy, strategic geographic locations, and increasing local content requirements. The UAE's Jebel Ali Free Zone and Dubai Industrial City, alongside Saudi Arabia's King Abdullah Economic City and Sudair Industrial City, stand out as key manufacturing hubs. These locations offer advanced infrastructure and logistical advantages, successfully attracting both domestic and international pharmaceutical companies. The region's commitment to life sciences is further bolstered by its strong academic credentials, as institutions such as King Saud University in KSA, Qatar University, and the United Arab Emirates University earn top spots in global life sciences university rankings. About JLL For over 200 years, JLL (NYSE: JLL), a leading global commercial real estate and investment management company, has helped clients buy, build, occupy, manage and invest in a variety of commercial, industrial, hotel, residential and retail properties. A Fortune 500® company with annual revenue of $23.4 billion and operations in over 80 countries around the world, our more than 112,000 employees bring the power of a global platform combined with local expertise. SEE A BRIGHTER WAYSM. About JLL MEA Across the Middle East and Africa (MEA) JLL is a leading player in the real estate and hospitality services markets. The firm has worked in 35 countries across the region and employs over 2000 internationally qualified professionals across its offices in Dubai, Abu Dhabi, Riyadh, Jeddah, Al Khobar, Cairo, Casablanca, Cape Town, Johannesburg and Nairobi.
Zawya
16 hours ago
- Zawya
INDEX signs agreement with Egypt's UPA to enhance strategic cooperation
INDEX Conferences and Exhibitions, a member of INDEX Holding and one of the UAE's leading organisers of specialised events, signed a Memorandum of Understanding (MoU) with the Egyptian Authority for Unified Procurement, Medical Supply, and Technology Management (UPA) during the fourth edition of Africa Health ExCon 2025 at the Egypt International Exhibition Centre. The MoU aims to enhance strategic cooperation between the two parties in organising medical conferences and exhibitions, leveraging advanced medical supply chain management expertise and unifying efforts to foster innovation, localise medical technologies, and broaden regional and international integration within the health sector. The partnership seeks to advance healthcare systems and strengthen regional health security. The MoU was signed by Amb. Dr. Abdulsalam AlMadani, Roving Ambassador of the Parliamentary Assembly of the Mediterranean (PAM) for the GCC Region, Chairman of INDEX Holding, and Dr. Hisham Siteit, Chairman of the Egyptian Authority for Unified Procurement, Medical Supply, and Technology Management (UPA), in the presence of Maj. Gen. Dr. Ahmed Amin, Senior Dentist of the Egyptian Armed Forces; Prof. Karim Mustafa Ibrahim Al-Batouti, Dean of the Faculty of Dentistry, Ain Shams University, Maj. Gen. Dr. Raafat Riyad, Professor at the Military Medical Academy; Tariq AlMadani, CEO of INDEX Conferences and Exhibitions; and Mrs. Sara AlMadani, CEO of INDEX Media. INDEX's participation reaffirms its commitment to actively shaping the global health events landscape and contributing meaningfully to a more innovative and efficient healthcare future. The conference is rapidly growing in impact and reach, attracting an increasing number of companies and organizations that view the platform as a gateway to expand their presence in Africa's promising market. Educational and awareness programs developed through such partnerships act as catalysts for enhancing health and well-being across the Arab world and the African continent. Amb. Dr. Abdulsalam AlMadani highlighted the strategic importance of collaborating with UPA, noting that the MoU opens new and impactful partnerships that underscore the UAE's pioneering role in supporting regional and global healthcare and education efforts. He stated, 'At INDEX Holding, we believe that building healthy, sustainable communities begins with strengthening regional and international collaboration, mobilising expertise, and aligning efforts between the public and private sectors. This partnership with the Egyptian UPA is a model of constructive cooperation between our two brotherly nations and reaffirms our unwavering commitment to advancing healthcare and scientific knowledge across the region. We view this agreement as a gateway to transformative initiatives that will deliver tangible improvements in health quality, in line with the Year of Community objectives and the UAE Centennial 2071 Plan.' Dr. Hisham Siteit confirmed that the UPA seeks to leverage INDEX Conferences and Exhibitions' extensive experience in managing international events, thereby boosting Egypt's institutional capabilities and advancing frameworks for healthcare communication and collaboration across the Arab and African regions. He stated, 'We believe in the importance of regional and international cooperation in developing the healthcare sector, particularly in medical technologies, continuing education, and knowledge exchange. This partnership will enable us to adopt global best practices in organising medical and scientific conferences.' Following the signing of the agreement, Amb. Dr. Abdulsalam AlMadani announced a pioneering educational initiative that grants all 40,000 participating doctors and speakers at Africa Health ExCon a one-year membership in the International Congress for Health Specialties (ICHS). This membership gives them access to the Congress's educational programs and the opportunity to attend lectures on the Waterfalls Global Initiative platform, which covers all medical and health specialties. The initiative is valued at approximately US$10 million.
